Published • loading... • Updated
Millions Set to Lose Healthcare Coverage in 2026 as Policy Shifts Accelerate; Prescription Hope Keeps Brand-Name Medications Within Reach for Americans
Up to 15 million could lose Medicaid as redeterminations proceed and enhanced ACA subsidies expire in 2026, reducing access to affordable healthcare and medications.
- Dec. 16, 2025, Prescription Hope warned the U.S. may see 15 million lose Medicaid and millions face rising costs as enhanced ACA subsidies expire in the coming year.
- Administrative changes and insurer shifts, including ongoing Medicaid eligibility redeterminations and employer plan transitions and rising deductibles, are prompting disenrollments and worsening insurance instability.
- Spending data show families now prioritize medications over utilities, and Prescription Hope helps eligible individuals access over 1,500 FDA-approved brand-name medications, charging a flat $70.00 per month per medication.
- The press release warns of reduced access to affordable care as the cumulative effect will limit affordable care and prescription drugs for millions of Americans, risking treatment loss for people managing chronic conditions.
- Patient Assistance Programs offer a nationwide pathway to keep therapies accessible, and individuals can begin enrollment at www.prescriptionhope.com or by calling 1-877-296-HOPE .
Insights by Ground AI
32 Articles
32 Articles
+31 Reposted by 31 other sources
Millions Set to Lose Healthcare Coverage in 2026 as Policy Shifts Accelerate; Prescription Hope Keeps Brand-Name Medications Within Reach for Americans
STUART, Fla., Dec. 16, 2025 /PRNewswire/ -- The United States is entering a period of significant disruption in healthcare coverage, according to health policy observers, with millions of Americans facing potential loss of coverage or sharply rising healthcare costs in…
Coverage Details
Total News Sources32
Leaning Left5Leaning Right1Center12Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 28%
C 67%
Factuality
To view factuality data please Upgrade to Premium











